Cargando…
Cellular and Molecular Mechanisms of Liver Fibrosis in Patients with NAFLD
SIMPLE SUMMARY: Nonalcoholic fatty liver disease (NAFLD) is rapidly becoming a major cause of cirrhosis and hepatocellular carcinoma (HCC). The risk of liver-related mortality, including HCC, significantly increases with the progression of liver fibrosis in NAFLD patients. This study aimed to charac...
Autores principales: | Sanchez, Jessica I., Parra, Edwin R., Jiao, Jingjing, Solis Soto, Luisa M., Ledesma, Debora A., Saldarriaga, Omar A., Stevenson, Heather L., Beretta, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252068/ https://www.ncbi.nlm.nih.gov/pubmed/37296834 http://dx.doi.org/10.3390/cancers15112871 |
Ejemplares similares
-
Spatial molecular and cellular determinants of STAT3 activation in liver fibrosis progression in non-alcoholic fatty liver disease
por: Jiao, Jingjing, et al.
Publicado: (2022) -
Genetic variants associated with steatohepatitis and liver fibrosis in HIV-infected patients with NAFLD
por: Busca, C., et al.
Publicado: (2022) -
Noninvasive serum biomarkers for liver fibrosis in NAFLD: current and future
por: Reinson, Tina, et al.
Publicado: (2023) -
Multicenter Validation Study of a Diagnostic Algorithm to Detect NASH and Fibrosis in NAFLD Patients With Low NAFLD Fibrosis Score or Liver Stiffness
por: Liebig, Stephanie, et al.
Publicado: (2019) -
The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver disease
por: Cichoż-Lach, Halina, et al.
Publicado: (2012)